Pomerantz LLP is investigating Pathward Financial following the company's fiscal Q3 2026 results, which missed expectations due to a surge in nonperforming loans, especially linked to renewable-energy projects. Pathward also lowered its earnings guidance for 2026. This disclosure caused the stock to drop 6.26% on July 23, 2026. The investigation focuses on whether Pathward and its executives engaged in securities fraud or other unlawful practices.
GH Research PLC has resolved the FDA clinical hold on its investigational new drug (IND) application for GH001, a treatment targeting resistant depression. This clearance allows the company to plan a pivotal phase 3 trial expected to begin in 2026. G...
The Congressional Black Caucus (CBC) is strongly supporting legislation to regulate artificial intelligence, with nearly all of its 62 members ready to vote in favor of AI guardrails to ensure transparency and safety. CBC leaders emphasize the need t...
The US State Department has urged Americans outside the Middle East to reconsider travel due to the risk of rapid escalation in the Iran conflict. Iran insists the Strait of Hormuz will remain closed until its demands are met, including ending the na...
Toyosa, a Toyota dealer in Bolivia, has introduced Bitcoin as a payment option for purchasing Toyota vehicles, adding to its existing payment methods including bolivianos, U.S. dollars, and USDT stablecoins. This expansion follows Bolivia's 2024 regu...
Metaplanet has reduced its stock compensation plan by 41%, lowering the potential shares from 319.5 million to 188.2 million, yet VanEck criticizes the plan as still excessively dilutive. The Japanese company’s stock plan represents 14.7% of fully di...
